View Author
endometrial foxo 1 cancer wnt /β-catenin progesterone expression /β-catenin treatment protein dkk 1 receptor endometrium ishikawa ishikawa cells endometrial cancer catenin inhibition cycle carcinoma analysis progesterone receptor ad-tmfoxo 1 endometrial carcinoma tumor regulation level factor staining foxo 1 expression phase control foxo 1 protein β- catenin endometrial stromal cells proliferation transcription skp 2 study forkhead vector sample apoptosi r 5020 treatment ad-tmfoxo pathway inhibitor growth cd 44 staining endometrial cancer cells hyperplasia stromal cell proliferation ai-ix increase progesterone receptors r 5020 estrogen • regulation women result group cd 44 tissue cell cycle progression foxo 1 stain rl 95 cells cd 44 expression gene expression data endometrial hyperplasia endocrinology tmfoxo 1 infection proliferative progestin cell lines endometrial carcinogenesis cluster transfected phosphorylation experiment
2 Most Recent Publications
|
Progesterone inhibition of Wnt/β-catenin signaling in normal endometrium and endometrial cancer
(Article)
Wang, Y. Hanifi-Moghaddam, P. Burger, C.W. Fodde, R. Blok, L.J. Hanekamp, E.E. Kloosterboer, H.J. Franken, P.F. Veldscholte, J. Doorn, H.C. van Ewing, P.C. Kim, J.J. Grootegoed, J.A. |
2009-09-15
|
|
The regulation and function of the Forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma
(Article)
Ward, E.C. Hoekstra, A.V. Blok, L.J. Hanifi-Moghaddam, P. Lurain, J.R. Singh, D.K. Buttin, B.M. Schink, J.C. Kim, J.J. |
2008-04-01
|
